Immunohistochemical staining of cytologic smears with MIB-1 helps distinguish low-grade from high-grade neuroendocrine neoplasms

被引:50
作者
Lin, O
Olgac, S
Green, I
Zakowski, MF
Klimstra, DS
机构
[1] Mem Sloan Kettering Canc Ctr, Cytol Serv, Dept Pathol, New York, NY 10021 USA
[2] Lenox Hill Hosp, Dept Pathol, New York, NY 10021 USA
关键词
proliferation; MIB-1; neuroendocrine; cytology; neoplasms;
D O I
10.1309/TGCD66L31DHYX5HK
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Neuroendocrine neoplasms (NENs) of the lung and gastrointestinal tract constitute a pathologic and biologic spectrum of tumors. Accurate cytologic diagnosis of a neuroendocrine neoplasm is important since definitive treatment frequently is based on low-and high-grade categories without histologic sampling. In many instances, however low- and high-grade NENs share cytologic features, hindering a precise classification. Since the histologic diagnostic criteria for separation of low-from high-grade categories can be based on the proliferation rate, we proposed to evaluate the usefulness of the immunocytochemical stain for the proliferation marker MIB-1 in the grading of NENs. Cytologic preparations of 63 NENs were retrieved from the files of Memorial Sloan-Kettering Cancer Center, New York, NY. One representative alcohol-fixed slide from each case was destained and restained immunocytochemically for MIB-1. When MIB-1 immunoreactivity was considered, all low-grade NENs showed immunoreactivity in fewer than 25% of the neoplastic cells, and all high-grade NENs demonstrated immunoreactivity in more than 50% of neoplastic cells. Our study demonstrates that MIB-1 dramatically; stratifies NENs as low-grade or high-grade. Therefore, the proliferation index also correlates with grade of NEN in cytology specimens.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 34 条
[1]  
ALKAISI N, 1992, ACTA CYTOL, V36, P655
[2]  
ANDERSON C, 1990, ACTA CYTOL, V34, P505
[3]   Neuroendocrine lung tumors: Grade correlates with proliferation but not angiogenesis [J].
Arbiser, ZK ;
Arbiser, JL ;
Cohen, C ;
Gal, AA .
MODERN PATHOLOGY, 2001, 14 (12) :1195-1199
[4]  
ARRIGONI MG, 1972, J THORAC CARDIOV SUR, V64, P413
[5]   The surgical management of pancreatic neuroendocrine tumors [J].
Azimuddin, K ;
Chamberlain, RS .
SURGICAL CLINICS OF NORTH AMERICA, 2001, 81 (03) :511-+
[6]  
Bohm J, 1996, J PATHOL, V178, P402, DOI 10.1002/(SICI)1096-9896(199604)178:4<402::AID-PATH498>3.0.CO
[7]  
2-5
[8]  
BUNN PA, 1997, SEMIN ONCOL S7, V24
[9]  
Cerilli L A, 2001, Am J Clin Pathol, V116 Suppl, pS65
[10]  
Collins BT, 1996, DIAGN CYTOPATHOL, V15, P37, DOI 10.1002/(SICI)1097-0339(199607)15:1<37::AID-DC8>3.0.CO